Tips for Tailoring eConsent for Optimal Patient Centricity
Over 70% of potential research participants live >2 hours away from a research site, & patient drop-out rates can reach 30% depending on the therapeutic area.
The Solution: eConsent
- Medable eConsent enables the enrollment of underrepresented, diverse populations through remote consenting.
- Medable eConsent has proven to reduce screening timelines by 50%, & increase patient engagement by 15%+.
Download the white paper to discover how to optimise eConsent for maximum patient centricity.
Medable's mission is to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. Our digital platform streamlines design, recruitment, & data management for decentralized trials, replacing siloed systems with integrated digital tools & interfaces to accelerate trial execution. We connect patients, sites, & sponsors to improve the experience for all. For more information, visit https://www.medable.com/.